Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 2, 2013, Pages 521-527

  Kashiwabuchi, Renata T ^a,c   Carvalho, Fabio R S ^a   Khan, Yasin A ^b   Hirai, Flavio ^a   Campos, Mauro S ^a   McDonnell, Peter J ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Rua Botucatu   (Brazil)

Author keywords

Candida albicans; Fusarium solani; Photodynamic therapy; Riboflavin; UV A light

Indexed keywords

RIBOFLAVIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL DEATH; CELL SIZE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FUNGAL CELL; FUNGAL STRAIN; FUNGAL VIABILITY; FUNGUS CULTURE; FUSARIUM SOLANI; HUMAN; KERATOCONUS; KERATOMYCOSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; FUSARIUM; MICROBIAL VIABILITY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84877147536     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2209-z     Document Type: Article

References (47)

1. Tuli SS (2011) Fungal keratitis. Clin Ophthalmol 5:275-279
2. Gopinathan U, Sharma S, Garg P, Rao GN (2009) Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 57(4):273-279
3. Chang HY, Chodosh J (2011) Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin 51(4):33-42
4. Mselle J (1999) Fungal keratitis as an indicator of HIV infection in Africa. Trop Doct 29(3):133-135
5. Thomas PA (2003) Fungal infections of the cornea. Eye (Lond) 17(8):852-862
6. Ganegoda N, Rao SK (2004) Antifungal therapy for keratomycoses. Expert Opin Pharmacother 5(4):865-874
7. Kalkanci A, Ozdek S (2011) Ocular fungal infections. Curr Eye Res 36(3):179-189
8. Vemuganti GK, Garg P, Gopinathan U, Naduvilath TJ, John RK, Buddi R, Rao GN (2002) Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology 109(8):1538-1546
9. Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100(1):44-49
10. Iseli HPTM, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5):590-594
11. Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118(2):324-331
12. Makdoumi KMJ, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29(12):1353-1358
13. Micelli Ferrari TLM, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19(2):295-297
14. Moren HMM, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29(1):102-104
15. Lonnen J, Kilvington S, Kehoe SC, Al-Touati F, McGuigan KG (2005) Solar and photocatalytic disinfection of protozoan, fungal and bacterial microbes in drinking water. Water Res 39(5):877-883
16. Spoerl EMM, Sliney D, Trokel S, Seiler T (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26:385-389
17. Ibrahim MM, de Angelis R, Lima AS, Viana de Carvalho GD, Ibrahim FM, Malki LT, de Paula Bichuete M, de Paula Martins W, Rocha EM (2012) A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil. PLoS One 7(3):e33775
18. Matsumoto YMD, Kojima T, Shimazaki J, Tsubota K (2011) The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol 95(10):1406-1409
19. Yavas GFOF, Küsbeci T, Cetinkaya Z, Ermis SS, Kiraz N, Inan UU (2008) Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol 246(2):275-279
20. Martin MJ, Rahman MR, Johnson GJ, Srinivasan M, Clayton YM (1995) Mycotic keratitis: susceptibility to antiseptic agents. Int Ophthalmol 19(5):299-302
21. Al-Sabai NKC, Tassignon MJ (2010) UVA/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophtalmol 315:13-17
22. Makdoumi KMJ, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250(1):95-102
23. Rama PDMF, Matuska S, Paganoni G, Spinelli A (2009) Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 35(4):788-791
24. Kashiwabuchi RT, Carvalho FR, Khan YA, de Freitas D, Foronda AS, Hirai FE, Campos MS, McDonnell PJ (2011) Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci 52(13):9333-9338
25. Wiwanitkit V (2010) Bactericidal effect of photo-activated riboflavin using UVA. Graefes Arch Clin Exp Ophthalmol 248(5):755
26. del Buey MACJ, Casas P, Goñi P, Clavel A, Mínguez E, Lanchares E, García A, Calvo B (2012) Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol 153(3):399-404
27. Martins SACJ, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49(8):3402-3408
28. Sauer AL-BV, Speeg-Schatz C, Touboul D, Colin J, Candolfi E, Bourcier T (2010) In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 51(8):3950-3953
29. Ou JI, Acharya NR (2007) Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 47(3):7-16
30. Ritterband DCSJ, Shah MK, Koplin RS, McCormick SA (2006) Fungal keratitis at the New York eye and ear infirmary. Cornea 25:264-267
31. Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B
32. Szentmáry NGS, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109(2):165-170
33. Chen ZXS, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol 92(9):1283-1286
34. Shih MHHF (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223-229
35. Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135(5):620-627
36. Sudhir PV, Ranjan DS, Ganpat AN (2010) Antifungal agents, WO2009025733. Expert Opin Ther Pat 20(1):137-143
37. Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). Rev Iberoam Micol 26(1):15-22
38. Bartnicki-Garcia S (1968) Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22:87-108
39. Adams DJ (2004) Fungal cell wall chitinases and glucanases. Microbiology 150(Pt 7):2029-2035
40. Nakagawa Y (2008) Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol Immunol 52(1):16-24
41. Kaplan JGPW (1956) The action of ultraviolet radiation on yeast catalase. J Gen Physiol 40(1):147-169
42. Cornforth JWRG, Robinson PM, Park D (1971) Isolation and characterization of a fungal vacuolation factor (bikaverin). J Chem Soc Perkin 1(16):2786-2788
43. Roberts J (1923) A budrot of the peach caused by a species of fusarium. J Agric Res XXVI(10):507-513
44. Taff HT NJ, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8:(e1002848)
45. Li JHK, Yumoto H, Matsuo T, Miyake Y, Ichikawa T (2010) Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms. J Appl Microbiol 109:2183-2190
46. Baillie GSDL (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46:397-403
47. Marcinkowska JKJ, Marquis LY (1982) Phytotoxic effects of cell-free cultural filtrates of Fusarium solani isolates on virulence, host specificity and resistance. Can J Plant Sci 62:1027-1035